Antigliadin and antiendomysium antibody determination for coeliac disease.
Open Access
- 1 August 1991
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 66 (8) , 941-947
- https://doi.org/10.1136/adc.66.8.941
Abstract
The value of IgG and IgA gliadin antibodies (AGA) was compared with that of IgA endomysium antibodies (EMA) for the diagnosis of coeliac disease. Three hundred and six of 340 (90%) children with untreated coeliac disease (flat mucosa) had EMA and 338/340 (99.4%) had IgG AGA and/or IgA AGA. Only 1/340 (a 7 year old boy with selective IgA deficiency) had neither AGA nor EMA. Absence of EMA is more frequent in coeliac patients younger than 2 years than in older patients (32/277 compared with 1/62). EMA were present in 4/211 (2%) of comparison subjects (normal mucosa), IgA AGA in 12/211 (6%), and IgG AGA in 74/211 (35%). The specificity of AGA cannot be calculated from these figures as they are biased. The combined determination of AGA and EMA, taking advantage of the high sensitivity of AGA and the high specificity of EMA, gives an excellent prediction of the condition of the mucosa: 247/248 patients (99.6%) with positive EMA and positive IgG AGA and IgA AGA had a flat mucosa, whereas 136/137 patients (99.3%) with neither AGA nor EMA had a normal mucosa. During a gluten free diet EMA and AGA disappear. Their presence or absence is therefore an indicator of dietary compliance. After reintroduction of gluten into the diet 110/134 (82%) of the patients who had a flat mucosa at diagnosis relapsed, but 24/134 still had a normal mucosa after 2-15 years of challenge. All these patients without a morphological relapse were less than 2 years old at diagnosis so we conclude that patients who are young at diagnosis should be challenged. AGA often reappear earlier than EMA. After one month of challenge 93% of patients are AGA and 69% EMA positive. After more than three years of gluten intake the percentage of AGA positive patients decreased to about 50% whereas the percentage of EMA positive sera was then highest (93%). Therefore EMA are more sensitive for the detection of 'silent' relapse after prolonged periods of gluten intake.Keywords
This publication has 29 references indexed in Scilit:
- Binding to human jejunum of serum IgA antibody from children with coeliac diseaseThe Lancet, 1990
- Postpubertal gluten challenge in coeliac disease.Archives of Disease in Childhood, 1989
- GLUTEN IgA ANTIBODIES AND COELIAC DISEASEThe Lancet, 1989
- Relationship of Endomysial Antibodies to Jejunal Mucosal PathologyJournal of Pediatric Gastroenterology and Nutrition, 1988
- Humoral response to alpha gliadin as serological screening test for coeliac disease.Archives of Disease in Childhood, 1987
- Changes of Serum Antibody Activities to Various Dietary Antigens Related to Gluten Withdrawal or Challenge in Children with Coeliac DiseaseInternational Archives of Allergy and Immunology, 1984
- Serum Gliadin Antibodies for Detection and Control of Childhood Coeliac DiseaseActa Paediatrica, 1984
- Serum IgG Antibodies to Gliadin in Children with Celiac Disease as Measured by an Immunofluorescence MethodJournal of Pediatric Gastroenterology and Nutrition, 1984
- A reliable screening test for childhood celiac disease: Fluorescent immunosorbent test for gliadin antibodies: A prospective multicenter studyThe Journal of Pediatrics, 1983
- A rapid fluorescent solid-phase method for detecting antibodies against milk proteins and gliadin in different immunoglobulin classesCellular and Molecular Life Sciences, 1972